Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy
Malini B. DeSilva(HealthPartners), Elyse O. Kharbanda(HealthPartners), Allison L. Naleway(Centers for Disease Control and Prevention), Darios Getahun(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente), Ousseny Zerbo(Kaiser Permanente), Jennifer C. Nelson(Kaiser Permanente Washington Health Research Institute), Candace C. Fuller(Harvard University), Heather S. Lipkind(Cornell University), Michael M. McNeil(Centers for Disease Control and Prevention), Jacob L. Haapala(HealthPartners), Eric Weintraub, Thomas G. Boyce(Centers for Disease Control and Prevention), Simon J. Hambidge, Joshua T.B. Williams(Denver Health Medical Center), Gabriela Vazquez‐Benitez, Kimberly K. Vesco(Kaiser Permanente)
Cited by 47
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
<i>Escherichia coli</i>O157:H7 and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1995|541
SARS–CoV-2 infection of the placenta
|Journal of Clinical Investigation|2020|492